These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12629763)

  • 21. [Recent achievements available for the treatment of hyperuricemia and gout. Preface].
    Hosoyamada M
    Nihon Yakurigaku Zasshi; 2010 Dec; 136(6):315. PubMed ID: 21218662
    [No Abstract]   [Full Text] [Related]  

  • 22. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.
    Jordan KM; Cameron JS; Snaith M; Zhang W; Doherty M; Seckl J; Hingorani A; Jaques R; Nuki G;
    Rheumatology (Oxford); 2007 Aug; 46(8):1372-4. PubMed ID: 17522099
    [No Abstract]   [Full Text] [Related]  

  • 23. A prescription for lifestyle change in patients with hyperuricemia and gout.
    Choi HK
    Curr Opin Rheumatol; 2010 Mar; 22(2):165-72. PubMed ID: 20035225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Time for a European perspective on cardiovascular prevention].
    Nilsson PM; Perk J; Rydén L
    Lakartidningen; 2008 Apr 2-8; 105(14):1000-4. PubMed ID: 18478749
    [No Abstract]   [Full Text] [Related]  

  • 25. Rules of engagement: turning recommendations into results in the diagnosis and management of gout.
    Grainger R; Harrison AA
    Int J Rheum Dis; 2015 Mar; 18(3):261-3. PubMed ID: 25923604
    [No Abstract]   [Full Text] [Related]  

  • 26. Gout and its comorbidities.
    Pillinger MH; Goldfarb DS; Keenan RT
    Bull NYU Hosp Jt Dis; 2010; 68(3):199-203. PubMed ID: 20969552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Austrian nutrition and lifestyle recommendations for gout and hyperuricemia].
    Sautner J; Eichbauer-Sturm G; Gruber J; Puchner R; Spellitz P; Strehblow C; Zwerina J; Eberl G;
    Z Rheumatol; 2015 Sep; 74(7):631-6. PubMed ID: 26014619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].
    Gysan DB; Latsch J; Bjarnason-Wehrens B; Albus C; Falkowski G; Herold G; Mey E; Heinzler R; Montiel G; Schneider CA; Stützer H; Türk S; Weisbrod M; Predel HG
    Z Kardiol; 2004 Feb; 93(2):131-6. PubMed ID: 14963679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hyperuricemia in hypertension].
    Tatsuno I
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():493-7. PubMed ID: 15171422
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperuricemia and tissue monourate deposits: prospective therapeutic considerations.
    Perez-Ruiz F; Punzi L
    Eur Rev Med Pharmacol Sci; 2015; 19(9):1549-52. PubMed ID: 26004589
    [No Abstract]   [Full Text] [Related]  

  • 31. [Gout].
    Carey Berner I; Dudler J
    Rev Med Suisse; 2006 Jan; 2(48):160-2. PubMed ID: 16463802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reply concerning the new Medical Products Agency's guidelines for primary prevention of cardiovascular diseases. Issuing recommendations based on available evidence basis an ethical duty].
    Beermann B
    Lakartidningen; 2006 Nov 22-28; 103(47):3731-2. PubMed ID: 17212324
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experience of treating gout and hyperuricemia from phlegm and stasis].
    Sun WF; Zhang XX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr; 31(4):463-4. PubMed ID: 21608212
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk factor management: a practice guide.
    Perk J
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S24-8. PubMed ID: 19675433
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases].
    Multi-Disciplinary Expert Task Force on Hyperuricemia and Its Related Diseases
    Zhonghua Nei Ke Za Zhi; 2017 Mar; 56(3):235-248. PubMed ID: 28253612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [ESH/ESC 2003].
    Umemura S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():562-8. PubMed ID: 16981591
    [No Abstract]   [Full Text] [Related]  

  • 37. Comment on: Gout: an independent risk factor for all-cause and cardiovascular mortality.
    Mascitelli L; Pezzetta F; Goldstein MR
    Rheumatology (Oxford); 2010 Jul; 49(7):1421-2; author reply 1422. PubMed ID: 20427295
    [No Abstract]   [Full Text] [Related]  

  • 38. Current world literature.
    Curr Opin Rheumatol; 2012 Mar; 24(2):237-44. PubMed ID: 22301869
    [No Abstract]   [Full Text] [Related]  

  • 39. [WHO/ISH 2003].
    Takeda K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():556-61. PubMed ID: 16981590
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support.
    Colvine K; Kerr AJ; McLachlan A; Gow P; Kumar S; Ly J; Wiltshire C; Robinson E; Dalbeth N
    N Z Med J; 2008 Nov; 121(1285):73-81. PubMed ID: 19079439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.